[REVISION HISTORY]

Iranian currency and financial market fluctuations

Updated 9 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-25 10:35 UTC → 2026-08-29 00:13 UTC · added ~~removed~~

The Iranian financial market continues to experience volatility across currency, precious metals, and digital assets. The US dollar in the free market has surpassed the 200,000 toman mark, a “psychological milestone” driven by structural factors such as commercial demand from importers and exporters facing year-end and Chinese New Year settlement deadlines. This surge is further complicated by the reliance on intermediary companies and trustee accounts in foreign jurisdictions due to sanctions, particularly following developments regarding Iranian accounts in the United Arab Emirates. By late August 2026, the US dollar exchange rate has shown minor increases, recording between 200,585 and 200,795 Tomans. The precious metals market remains active; while 18-karat gold prices have seen slight increases toward the 21,746,800 Toman range per gram, the Bahar Azadi and Imam gold coins have experienced price declines. In response to economic instability and intensifying US sanctions, Supreme Leader Mojtaba Khamenei has issued directives emphasizing domestic production as the essential solution to inflation and market volatility. He also called for a gradual reduction in the influence of the US dollar within the national economy. The currency spike ~~has~~ maintains a dual impact on tourism: while a weaker rial could theoretically make Iran more affordable for foreigners, it significantly increases the cost of international travel for Iranian citizens, potentially shifting demand toward domestic destinations. Regarding the pharmaceutical sector, officials ~~have clarified that while a~~ continue to manage the gradual reduction of preferential currency for ~~medicines has begun through cooperation~~ medicines, with the ~~Central Bank,~~ ‘Daruyar’ scheme acting as a ~~complete removal of these subsidies is not currently on the agenda~~ buffer for this year. This reduction has already affected the procurement of certain medicines, such as insulin, and raw pharmaceutical materials. To mitigate impacts on patients, the difference in funds is being redirected to the ‘Daruyar’ scheme. Despite the reduction, $3 billion of the government’s $8.8 billion foreign exchange income has been allocated to medicines, with parliamentary and executive opposition expected to prevent the total removal of these subsidies in upcoming budget proposals. patients.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.